Educational information, not medical advice.See how evidence is graded

Nicotinamide Mononucleotide (NMN)

Best studied for: Age-related energy decline; Metabolic health; Cognitive function. Supports healthy aging, energy metabolism, cognitive sharpness.

Home

What is it? Nicotinamide Mononucleotide (NMN) is a nucleotide derived from ribose and nicotinamide. It is a precursor to nicotinamide adenine dinucleotide (NAD+), a critical coenzyme in cellular energy metabolism and DNA repair. How does it work for medicinal purposes? NMN works by increasing levels of NAD+, which is essential for energy production in cells, DNA repair, and the activation of certain enzymes like sirtuins that are involved in longevity and metabolic regulation. Higher NAD+ levels support mitochondrial function, enhance cellular energy, and improve overall cellular health. Active Ingredients: The active ingredient is nicotinamide mononucleotide, which is converted in the body to NAD+. Forms: NMN is available in various forms including capsules, tablets, powders, and sublingual supplements. Imbalance or Deficiency: A deficiency in NAD+ can lead to symptoms of fatigue, metabolic disorders, and accelerated aging. Supplementing with NMN can help restore NAD+ levels, potentially improving energy metabolism and reducing age-related decline. First Medicinal Use: NMN research began gaining significant attention in the early 2000s. Its use as a supplement for boosting NAD+ levels has been more recent, with increasing research supporting its benefits in the past decade.

Helps

What does Nicotinamide Mononucleotide (NMN) help with? NMN is a supplement the body turns into NAD+. NAD+ is a helper molecule that cells use to make energy. That much is well-established basic biology, not a claim about NMN pills. Low energy and tiredness as you get older Good evidence — several human trials in older adults, using self-rated energy scores. In trials of older adults, NMN raised NAD+ levels in the blood. Several of those trials found better energy and fatigue scores within weeks. Those scores came from how people rated themselves, not from lab tests. Evidence grade B · Traditional tier T0 Stamina and breathing ease during exercise Good evidence — one Japanese placebo-controlled trial in recreational runners. One Japanese trial gave NMN or a placebo to recreational runners. The NMN group used oxygen more efficiently while exercising. Our file does not record the dose or the number of runners. Evidence grade B · Traditional tier T0 Blood sugar and body weight control Early evidence — small human trials in postmenopausal women and older adults. Human trials in postmenopausal women and older adults have tested NMN. They point to a better response to insulin, and to muscle using glucose more efficiently. The trials were small, and no dose is listed in our file. Evidence grade C · Traditional tier T0 Brain fog and slipping mental sharpness Early evidence — early, small human studies of thinking skills and sleep. Early human studies have looked at thinking skills in people taking NMN. The results hint at some support for mental sharpness. The studies are small and early, so the picture is far from clear. Evidence grade C · Traditional tier T0 Poor sleep Evidence doesn't support this — sleep reported as a side finding; no trial built to test sleep. Some people in NMN trials said their sleep felt better. NAD+ takes part in the body clock, but that link rests on lab work. No trial on file was designed to test sleep on its own. Evidence grade D · Traditional tier T0 Heart and blood vessel health Evidence doesn't support this — some human marker studies; no completed outcome trials. Some human research has looked at artery flexibility and heart markers with NMN. Those findings are early and not consistent. No large trial has yet tracked heart attacks or strokes. Evidence grade D · Traditional tier T0 Slowing aging and living longer Not yet tested in people — lab and animal work only; no human lifespan data. NAD+ helps run DNA repair enzymes called sirtuins and PARPs. That link comes from lab and animal research, not from trials in people. No human study has measured how long NMN users live. Evidence grade insufficient · Traditional tier T0 Fading eyesight with age Not yet tested in people — animal models only; human eye trials still under way. In animal models, NMN gave strong protection against age-related retina damage. Lab science shows NAD+ matters for the energy supply of retinal cells. Human eye trials are still running, and none on file have finished. Evidence grade insufficient · Traditional tier T0 What Nicotinamide Mononucleotide (NMN) has not been shown to do No human study has shown that NMN makes people live longer. No completed trial has shown that NMN prevents heart attacks or strokes. NMN has not been shown to prevent or reverse dementia. No dedicated sleep trial has shown that NMN fixes insomnia. No finished human trial has shown that NMN protects your eyesight. Raising NAD+ in the blood has not been shown to reverse aging itself. How to read this: The grades rate the human evidence, not how strong the effect feels. A means steady results across randomised trials in people. B means at least one good randomised human trial. C means small or early human studies. D means the human evidence is weak or mixed. Insufficient means lab work, animal work or theory only. This page lists options and findings. It is not medical advice, and it is not a promise that NMN will help you.

Nicotinamide Mononucleotide (NMN)

Nicotinamide Mononucleotide (NMN)

Quick Facts

  • What it is: A naturally occurring molecule your body uses to make NAD+, a compound essential for energy production and cellular repair.
  • Main uses: Supports healthy aging, energy metabolism, cognitive sharpness, and physical endurance — especially in people over 40 whose NAD+ levels have dropped.
  • Best for: Age-related energy decline, Metabolic health, Cognitive function
  • Active ingredients: Nicotinamide Mononucleotide (NMN), NAD+ (as downstream product)
  • Forms: capsule, sublingual tablet, powder, sublingual liquid, IV (clinical settings only)
  • Time to effect: Energy and sleep changes may appear within 2–4 weeks; longer-term benefits like metabolic and cognitive improvements typically take 8–12 weeks.
  • Side effects: Generally well tolerated at studied doses; some people notice mild nausea or flushing at higher amounts.
  • Pregnancy & breastfeeding: Not studied in pregnancy; avoid unless your clinician advises otherwise.

Educational information, not medical advice — ask your doctor or midwife.

Track this remedy in the app

Track Nicotinamide Mononucleotide (NMN) with reminders and see your options for Cellular Regeneration in the app.

Download on the App StoreGet it on Google Play

What is it?

Nicotinamide Mononucleotide (NMN) is a nucleotide derived from ribose and nicotinamide. It is a precursor to nicotinamide adenine dinucleotide (NAD+), a critical coenzyme in cellular energy metabolism and DNA repair.

How does it work for medicinal purposes?

NMN works by increasing levels of NAD+, which is essential for energy production in cells, DNA repair, and the activation of certain enzymes like sirtuins that are involved in longevity and metabolic regulation. Higher NAD+ levels support mitochondrial function, enhance cellular energy, and improve overall cellular health.

Active Ingredients:

The active ingredient is nicotinamide mononucleotide, which is converted in the body to NAD+.

Forms:

NMN is available in various forms including capsules, tablets, powders, and sublingual supplements.

Imbalance or Deficiency:

A deficiency in NAD+ can lead to symptoms of fatigue, metabolic disorders, and accelerated aging. Supplementing with NMN can help restore NAD+ levels, potentially improving energy metabolism and reducing age-related decline.

First Medicinal Use:

NMN research began gaining significant attention in the early 2000s. Its use as a supplement for boosting NAD+ levels has been more recent, with increasing research supporting its benefits in the past decade.

If this is an emergency

Some reactions to Nicotinamide Mononucleotide (NMN) need urgent care. Call your local emergency number or go to an emergency department straight away — do not wait to see whether it passes.

Who should avoid Nicotinamide Mononucleotide (NMN)?

  • Do not take NMN if you are pregnant or trying to get pregnant, since it has not been tested in pregnancy.
  • Do not take NMN while breastfeeding.
  • Do not give NMN to children or teens.
  • Do not take NMN if you have cancer now or had it in the past, unless your cancer doctor says it is fine.
  • Do not add NMN to any prescription drug without asking your doctor or pharmacist first.
  • Do not start higher than 250 mg a day; raise the dose slowly if you want more.
  • Do not take more than 900 mg a day, the highest dose used in trials.
  • Avoid taking NMN late in the day, since it can disturb sleep or make you tired.
  • Avoid taking NMN on an empty stomach if it makes you feel sick; take it with a small meal.
  • Do not push through strong flushing or skin warmth; lower the dose or stop.
  • Do not assume daily use past one year is proven safe, as long-term data is still thin.

When should you see a doctor?

Most effects are mild and fade. Call your doctor if a headache lasts more than a few days. Do the same if nausea, stomach upset or poor sleep does not ease within a week of stopping.

Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.

Reviewed by the HealisticMD editorial team How we grade evidence →

Remedies related to Nicotinamide Mononucleotide (NMN)

People take Nicotinamide Mononucleotide (NMN) when they say

Everyday descriptions of the problems this remedy is recommended for.

Conditions where Nicotinamide Mononucleotide (NMN) is recommended

Each grade below is for that condition specifically, not for Nicotinamide Mononucleotide (NMN) in general.

The evidence behind this remedy, in one page

What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.

One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.